Medical Device Network on MSN
Valar Labs hits US first with breakthrough designation for AI bladder cancer test
Valar Labs’ Vesta Bladder Risk Stratify Dx generates risk assessments for bladder cancer patients by analysing stained ...
The assay delivers a risk score that can help clinicians to tailor treatment intensity to a patient's risk of disease progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results